Dublin, Oct. 12, 2020 (GLOBE NEWSWIRE) — The “International Markets for Therapy and Analysis of Sexually Transmitted Illnesses” report has been added to ResearchAndMarkets.com’s providing.
The scope of this report contains an summary of the worldwide market situation for analysis and coverings of sexually transmitted illnesses with base yr information of 2019 and forecast for 2020-2025 Market information in value phrases is supplied at international, regional, and nation ranges for illness areas and therapy by drug class. Market information for sexually transmitted illness diagnostics is supplied for regional ranges, with particulars on check varieties. The report focuses on key sectional assessments for main illness areas resembling chlamydia, genital herpes, HIV, and hepatitis, amongst others, and gives detailed evaluation of epidemiology, historic and present illness incidence tendencies, therapeutic interventions, and diagnostic overview. It forecasts the worldwide market by drug class for the therapy of STDs and discusses market information for antibiotics, antivirals/antiretrovirals, and different remedies. Diagnostic check varieties resembling enzyme immunoassays (EIA) and ELISA, PCR, fast diagnostics, and others, are detailed with market information present and forecasts. The regional overviews present data on the epidemiology of sexually transmitted illnesses by nation and area and in addition particulars market information for every area. The regulatory situation is mentioned for the USA, Europe, Japan, and China to supply an summary of the laws for brand spanking new drug launches and diagnostic kits. The reimbursement situation is printed for the USA, Europe, and Japan to supply an summary to our readers. The Report Contains: An outline of the worldwide markets for therapy and analysis of sexually transmitted diseasesAnalyses of the worldwide market tendencies, with corresponding market evaluation information for 2019, estimates for 2020, and projections of compound annual development charges (CAGRs) by way of 2025Analysis of the impression of demographic, financial, and different components that can drive future demand for diagnostic and therapeutic interventions affecting the sexually transmitted illnesses marketEstimation of market dimension and forecast the potential marketplace for sexually transmitted illness therapeutics, together with international market share evaluation on the premise of illness space and coverings, drug sort, and geographical regionIdentification of unmet wants in sexually transmitted illnesses therapeutics, promising new medicine and therapies nonetheless within the growth and testing stage that might be commercialized efficiently within the subsequent 5 yearsAssessment of the long-term outlook for sexually transmitted illnesses therapeutics, contemplating market alternatives in addition to technological, monetary, and financial factorsInsight into the components driving and restraining the expansion of the worldwide marketplace for therapy and analysis of sexually transmitted illnesses, together with a regional market overview for North America, Europe, Asia-Pacific, Latin America, and the Center EastCompany profiles of the main drug producers and suppliers, market together with Abbott Laboratories, AbbVie Inc., Novartis AG, Pfizer Inc., and Thermo Fisher Scientific Inc.Key Subjects Coated:
Chapter 1 Introduction Chapter 2 Abstract and Highlights Chapter three International Market Overview and Traits Overview of Sexually Transmitted Illnesses and DefinitionsSexually Transmitted Illnesses and PregnancyScreening Packages and GuidelinesMobile HIV Testing in BrazilBenzathine Penicillin Drug ShortageTrends within the International Transmission of STDsIncreasing Incidence of STDsSTD Consciousness and Screening ServicesDevelopment of Take a look at Kits with Excessive Sensitivity for Low Useful resource SettingsChallengesUnderestimating the Danger of Contracting the DiseaseSocial Stigma Related to STDsRising Incidence of Antibiotic ResistanceLack of Prenatal Screening for STDsChapter four Illness Overview ChlamydiaOverviewEpidemiologyDiagnosisTreatmentsGenital HerpesGonorrheaHepatitis A, B and CHIV/AIDSHPVSyphilisOthersChapter 5 STD Analysis and Therapy Choices Introduction to STD Diagnostics by Take a look at TypeEnzyme Immunoassay (EIA) and ELISAPolymerase Chain Response (PCR)Speedy Diagnostics Checks (RDTs)OthersIntroduction to Therapy by Drug ClassAntibiotics/AntibacterialAntiviral/ AntiretroviralsOthersChapter 6 North American Market Chapter 7 European Market Chapter eight Asia-Pacific Market Chapter 9 Remainder of the World Market Chapter 10 Regulatory Construction Overview of RegulationsUnited StatesEuropeJapanChinaOverview of Pricing and ReimbursementUnited StatesEuropeJapanChapter 11 Firm Profiles Abbott LaboratoriesAbbvie Inc.Agilent Applied sciences Inc.Becton, Dickinson and Co.Biomerieux Inc.Bio-Rad Laboratories Inc.Boehringer Ingelheim Prescribed drugs, Inc.Bristol-Myers Squibb Co.Cepheid Inc.Gilead Sciences Inc.Glaxosmithkline PlcHoffmann-La Roche Inc.Hologic Inc.Merck & Co. Inc.Novartis AgPfizer Inc.Promega Corp.Qiagen N.V.Quidel Corp.Thermo Fisher Scientific Inc.Chapter 12 Appendix For extra details about this report go to https://www.researchandmarkets.com/r/df6vkc
Analysis and Markets additionally affords Customized Analysis providers offering centered, complete and tailor-made analysis. CONTACT: ResearchAndMarkets.com
Laura Wooden, Senior Press Supervisor
For E.S.T Workplace Hours Name 1-917-300-0470
For U.S./CAN Toll Free Name 1-800-526-8630
For GMT Workplace Hours Name +353-1-416-8900